Neuropsychiatric symptoms (NPS) are increasingly being recognized as clinical markers for incipient dementia in Alzheimer’s disease (AD dementia). NPS may reinforce cognitive impairment or decline and vice versa. Although NPS are frequent already in mild cognitive impairment, their mechanisms are poorly understood. It is unclear if they share biological mechanisms with cognitive symptoms and how they are associated to structural brain changes, but evidence suggests associations of NPS to cerebral atrophy. An additional NPS dimension in AD dementia concepts might add valuable information to detect patients at risk for AD dementia.
CummingsJ (2021) The role of neuropsychiatric symptoms in research diagnostic criteria for neurodegenerative diseases. Am J Geriatr Psychiatry29, 375–383.
2.
LyketsosCG, LopezO, JonesB, FitzpatrickAL, BreitnerJ, DeKoskyS (2002) Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA288, 1475–1483.
3.
GallagherD, FischerCE, IaboniA (2017) Neuropsychiatric symptoms in mild cognitive impairment. Can J Psychiatry62, 161–169.
4.
IsmailZ, GatchelJ, BatemanDR, Barcelos-FerreiraR, CantillonM, JaegerJ, DonovanNJ, MortbyME (2018) Affective and emotional dysregulation as pre-dementia risk markers: Exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria. Int Psychogeriatr30, 185–196.
5.
TaraganoFE, AllegriRF, HeiseckeSL, MartelliMI, FeldmanML, SánchezV, GarcíaVA, TufroG, CastroDM, LeguizamónPP, GuelarV, RuotoloE, ZegarraC, DillonC (2018) Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group. J Alzheimers Dis62, 227–238.
6.
ForresterSN, GalloJJ, SmithGS, LeoutsakosJM (2016) Patterns of neuropsychiatric symptoms in mild cognitive impairment and risk of dementia. Am J Geriatr Psychiatry24, 117–125.
7.
LeoutsakosJM, ForresterSN, LyketsosCG, SmithGS (2015) Latent classes of neuropsychiatric symptoms in NACC controls and conversion to mild cognitive impairment or dementia. J Alzheimers Dis48, 483–493.
8.
IsmailZ, SmithEE, GedaY, SultzerD, BrodatyH, SmithG, Aguera-OrtizL, SweetR, MillerD, LyketsosCG (2016) Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement12, 195–202.
9.
NagataT, ShinagawaS, NakajimaS, MimuraM, ShigetaM (2018) Association between neuropsychiatric improvement and neurocognitive change in alzheimer’s disease: Analysis of the CATIE-AD Study. J Alzheimers Dis66, 139–148.
10.
NagataT, IshiiK, ItoT, AokiK, EharaY, KadaH, FurukawaH, TsumuraM, ShinagawaS, KasaharaH, NakayamaK (2009) Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer’s disease. Psychiatry Clin Neurosci63, 449–454.
11.
DasguptaM, HillierLM (2010) Factors associated with prolonged delirium: A systematic review. Int Psychogeriatr22, 373–394.
12.
PoulinSP, BergeronD, DickersonBC (2017) Risk factors, neuroanatomical correlates, and outcome of neuropsychiatric symptoms in Alzheimer’s disease. J Alzheimers Dis60, 483–493.
13.
GedaYE, SchneiderLS, GitlinLN, MillerDS, SmithGS, BellJ, EvansJ, LeeM, PorsteinssonA, LanctôtKL, RosenbergPB, SultzerDL, FrancisPT, BrodatyH, PadalaPP, OnyikeCU, OrtizLA, Ancoli-IsraelS, BliwiseDL, MartinJL, VitielloMV, YaffeK, ZeePC, HerrmannN, SweetRA, BallardC, KhinNA, AlfaroC, MurrayPS, SchultzS, LyketsosCG (2013) Neuropsychiatric symptoms in Alzheimer’s disease: Past progress and anticipation of the future. Alzheimers Dement9, 602–608.
14.
ScheltensP, KorfES (2000) Contribution of neuroimaging in the diagnosis of Alzheimer’s disease and other dementias. Curr Opin Neurol13, 391–396.
15.
Tabatabaei-JafariH, ShawME, CherbuinN (2015) Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis. Alzheimers Dement (Amst)1, 487–504.
16.
BoublayN, SchottAM, Krolak-SalmonP (2016) Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer’s disease: A review of 20 years of research. Eur J Neurol23, 1500–1509.
Marin-MarinL, Renau-LagranjaJ, ÁvilaC, CostumeroV (2024) Depression and agitation factors are related to regional brain atrophy and faster longitudinal cognitive decline in mild cognitive impairment.. J Alzheimers Dis97, 1341–1351.
19.
SiafarikasN, SelbaekG, FladbyT, Saltyte BenthJ, AuningE, AarslandD (2018) Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer’s disease. Int Psychogeriatr30, 103–113.
20.
DhikavV, SethiM, AnandKS (2014) Medial temporal lobe atrophy in Alzheimer’s disease/mild cognitive impairment with depression. Br J Radiol87, 20140150.
21.
AuningE, SelnesP, GrambaiteR, Šaltytė BenthJ, HaramA, Løvli StavA, BjørnerudA, HessenE, HolPK, Muftuler løndalenA, FladbyT, AarslandD (2015) Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment. Acta Psychiatr Scand131, 139–147.
22.
NowrangiMA, RosenbergPB (2021) Is bigger better? Towards a mechanistic understanding of neuropsychiatric symptoms in Alzheimer’s disease. Int Psychogeriatr33, 1129–1133.
23.
SerraL, GiuliettiG, CercignaniM, SpanòB, TorsoM, CastelliD, PerriR, FaddaL, MarraC, CaltagironeC, BozzaliM (2013) Mild cognitive impairment: Same identity for different entities. J Alzheimers Dis33, 1157–1165.
24.
World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders diagnostic criteria for research; ICD-10, WHO, Geneva.
PolcherA, WolfsgruberS, PetersO, FrölichL, WiltfangJ, KornhuberJ, HüllM, RütherE, LewczukP, MaierW, JessenF, WagnerM (2022) A comparison of operational definitions for mild cognitive impairment. J Alzheimers Dis88, 1663–1678.
27.
MiaoR, ChenHY, GillS, NaudeJ, SmithEE, IsmailZ (2022) Plasma β-amyloid in mild behavioural impairment –neuropsychiatric symptoms on the Alzheimer’s continuum. J Geriatr Psychiatry Neurol35, 434–441.
28.
KassamF, ChenH, NoshenyRL, McGirrA, WilliamsT, NgN, CamachoM, MackinRS, WeinerMW, IsmailZ (2023) Cognitive profile of people with mild behavioral impairment in Brain Health Registry participants. Int Psychogeriatr35, 643–652.
JesteDV, FinkelSI (2000) Psychosis of Alzheimer’s disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry8, 29–34.
31.
FischerCE, IsmailZ, YouakimJM, CreeseB, KumarS, NuñezN, Ryan DarbyR, Di VitaA, D’AntonioF, de LenaC, McGeownWJ, RamitR, RasmussenJ, BellJ, WangH, BruneauMA, PanegyresPK, LanctôtKL, Agüera-OrtizL, LyketsosC, CummingsJ, JesteDV, SanoM, DevanandDP, SweetRA, BallardC (2020) Revisiting criteria for psychosis in Alzheimer’s disease and related dementias: Toward better phenotypic classification and biomarker research. J Alzheimers Dis73, 1143–1156.
CummingsJ, MintzerJ, BrodatyH, SanoM, BanerjeeS, DevanandDP, GauthierS, HowardR, LanctôtK, LyketsosCG, PeskindE, PorsteinssonAP, ReichE, SampaioC, SteffensD, WortmannM, ZhongK (2015) Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. Int Psychogeriatr27, 7–17.
34.
ChenTH, YehYC, HuangMF, ChenHM, LeeJI, ChenCS (2022) Validation and comparison of the informant-rated and self-rated versions of the Mild Behavioral Impairment Checklist. J Alzheimers Dis90, 1203–1213.
35.
KanCN, CanoJ, ZhaoX, IsmailZ, ChenCL, XuX (2022) Prevalence, clinical correlates, cognitive trajectories, and dementia risk associated with mild behavioral impairment in Asians. J Clin Psychiatry83, 21m14105.
36.
BurhanullahMH, TschanzJT, PetersME, LeoutsakosJM, MatyiJ, LyketsosCG, NowrangiMA, RosenbergPB (2020) Neuropsychiatric symptoms as risk factors for cognitive decline in clinically normal older adults: The Cache County Study. Am J Geriatr Psychiatry28, 64–71.
37.
LewisPA, SpillaneJE(2018) The molecular and clinical pathology of neurodegenerative disease. Academic Press London, London.
38.
HsuJL, LeeWJ, LiaoYC, LirngJF, WangSJ, FuhJL (2015) Posterior atrophy and medial temporal atrophy scores are associated with different symptoms in patients with Alzheimer’s disease and mild cognitive impairment. PLoS One10, e0137121.
39.
BaoY, WangY, WangW, WangY (2017) The superior fronto-occipital fasciculus in the human brain revealed by diffusion spectrum imaging tractography: An anatomical reality or a methodological artifact? . Front Neuroanat11, 119.
40.
GillS, WangM, MouchesP, RajashekarD, SajobiT, MacMasterFP, SmithEE, ForkertND, IsmailZ (2021) Neural correlates of the impulse dyscontrol domain of mild behavioral impairment. Int J Geriatr Psychiatry36, 1398–1406.
41.
RosenbergPB, NowrangiMA, LyketsosCG (2015) Neuropsychiatric symptoms in Alzheimer’s disease: What might be associated brain circuits? . Mol Aspects Med43-44, 25–37.
SamaraA, TsangarisGT (2011) Brain asymmetry: Both sides of the story. Expert Rev Proteomics8, 693–703.
44.
HeF, LiY, LiC, ZhaoJ, LiuT, FanL, ZhangX, WangJ (2021) Changes in the connection network of whole-brain fiber tracts in patients with Alzheimer’s disease have a tendency of lateralization. Neuroreport32, 1175–1182.
45.
GuoY, PaiM, XueB, LuW (2023) Bidirectional association between depressive symptoms and mild cognitive impairment over 20 years: Evidence from the Health and Retirement Study in the United States. J Affect Disord338, 449–458.
46.
GillS, MouchesP, HuS, RajashekarD, MacMasterFP, SmithEE, ForkertND, IsmailZ (2020) Using machine learning to predict dementia from neuropsychiatric symptom and neuroimaging data. J Alzheimers Dis75, 277–288.
47.
ShahJ, Rahman SiddiqueeMM, Krell-RoeschJ, SyrjanenJA, KremersWK, VassilakiM, ForzaniE, WuT, GedaYE (2023) Neuropsychiatric symptoms and commonly used biomarkers of Alzheimer’s disease: A literature review from a machine learning perspective. J Alzheimers Dis92, 1131–1146.
